<bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

被引：0

作者：

Lazaridis, Lazaros ^{[1
]}

Schaefer, Niklas ^{[2
]}

Schmidt, Teresa ^{[3
]}

Weller, Johannes ^{[2
]}

Tzaridis, Theophilos-Dimitrios ^{[2
]}

Scheffler, Bjoern ^{[4
]}

Pierscianek, Daniela ^{[5
]}

Kleinschnitz, Christoph ^{[6
]}

Stuschke, Martin ^{[7
]}

Sure, Ulrich ^{[5
]}

Herrlinger, Ulrich ^{[2
]}

Kebir, Sied ^{[1
]}

Glas, Martin ^{[3
]}

机构：

[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[2] Univ Bonn, Div Clin Neurooncol, Dept Neurol, Med Ctr, Bonn, Germany

[3] Univ Duisburg Essen, Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[4] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, West German Canc Ctr WTZ, DKFZ,Div Translat Neurooncol, Essen, Germany

[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg, Essen, Germany

[6] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany

[7] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiotherapy, Essen, Germany

来源：

NEURO-ONCOLOGY | 2019年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

RARE-39

引用

页码：229 / 230

页数：2

共 50 条

[21] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) IN THE EF-14 PHASE 3 CLINICAL STUDY - A SAFETY ANALYSIS
Kinzel, Adrian
Lavy-Shahaf, Gitit
Kirson, Eilon
NEURO-ONCOLOGY, 2018, 20 : 23 - 23
[22] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) IN THE EF-14 PHASE 3 CLINICAL STUDY - A SAFETY ANALYSIS
Kinzel, A.
Lavy-Shahaf, G.
Kirson, E.
NEURO-ONCOLOGY, 2018, 20 : 244 - 244
[23] Tumor Treating Fields Combine with Temozolomide for Newly Diagnosed Glioblastoma: A Retrospective Analysis of Chinese Patients in a Single Center
Chen, Chunjui
Xu, Hao
Song, Kun
Zhang, Yi
Zhang, Junyan
Wang, Yang
Sheng, Xiaofang
Chen, Lingchao
Qin, Zhiyong
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[24] RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Wang, Yang
Wu, Jingsong
Qin, Zhiyong
Wang, Enmin
Yao, Yu
Zhuang, Dongxiao
Liang, Lipin
Ni, Chunxia
Lu, Peijiang
Chen, Shu
Li, Chao
NEURO-ONCOLOGY, 2021, 23 : 72 - 72
[25] PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
Grossman, Rachel
Limon, Dror
Bokstein, Felix
Ben Harosh, Carmit
Blumenthal, Deborah
Ram, Zvi
NEURO-ONCOLOGY, 2020, 22 : 196 - 196
[26] Efficacy Of Tumor Treating Fields (TTFields) In Elderly Patients With Newly Diagnosed Glioblastoma (GBM): Sub-Group Analysis Of The Phase 3 EF-14 Trial
Ram, Z.
Zhu, J. J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E730 - E731
[27] Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients
Mehta, M.
Wen, P.
Nishikawa, R.
Reardon, D.
Peters, K.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 60 - 65
[28] Association of Tumor Treating Fields (TTFields) with survival in newly diagnosed glioblastoma: A systematic review and meta-analysis
Conlon, Patrick
Lavy-Shahaf, Gitit
Urman, Noa
Ballo, Matthew T.
CANCER RESEARCH, 2023, 83 (07)
[29] PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE plus /- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA
Shi, Wenyin
Kleinberg, Lawrence
Jeyapalan, Suriya A.
Goldlust, Samuel
Nagpal, Seema
Combs, Stephanie E.
Roberge, David
Nishigawa, Ryo
Grossman, Rachel
Glas, Martin
NEURO-ONCOLOGY, 2020, 22 : 59 - 60
[30] Efficacy of tumor treating fields (TTFields) in elderly patients with newly diagnosed glioblastoma (GBM): Sub-group analysis of the phase III EF-14 trial.
Ram, Zvi
Kim, Chae-Yong
Zhu, Jay-Jiguang
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →